Medical Review Board

We want to change the game—or at least, be a catalyst in directing MS research dollars toward a cure. Building on our long-standing commitment to the University of Arkansas-Medical Science (UAMS), we established a Medical Review Board to help us identify and support MS researchers focused on remyelination—the believed pathway to a cure within the scientific community.

At current, finding a cure is a numbers game. A cure is only so close as research monies that get directed to discovering it. While research has progressed to help people live with this disease, we imagine a world where people don’t have to.

Robert L. Archer, M.D.

Dr. Robert L. Archer is a professor of neurology at the Jackson T. Stephens Spine and Neurosciences Institute at the University of Arkansas for Medical Sciences (UAMS). He works hard to provide relief to patients dealing with neurological challenges from multiple sclerosis (MS). He completed his medical degree at UAMS and later served a neurology residency here as well. Dr. Archer is board certified in neurology by the American Board of Psychiatry and Neurology.

Paul D. Drew, PhD

Dr. Drew conducts research in the field of Neuroimmunology. Normally, immune activity in the brain is limited. However, in diseases including multiple sclerosis, Alzheimer’s disease, and alcohol abuse activated immune cells are observed in the brain. These immune cells produce cytokines which may be toxic to brain cells as well as chemokines which direct cells to sites of inflammation, resulting in neuropathology. Dr. Drew’s research involves modern cellular and molecular biology techniques..

Patricia A. Wight, PhD

Dr. Wright’s lab research is centered on CNS development, particularly with regard to the formation and maintenance of myelin. Myelin is the tightly compacted multilamellar sheath that surrounds axons and promotes saltatory conduction of nerve impulses..